Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors

Magnetic Resonance Imaging Clinics of North America

Volumn 19, Issue 1, 2011, Pages 159-180

  Costa, Flávia Martins ^a   Ferreira, Elisa Carvalho ^a   Vianna, Evandro Miguelote ^a  

^a Section of Pediatric Radiology   (Brazil)

Author keywords

Contrast enhancement; Diffusion weighted imaging; Hyperintensity; Musculoskeletal tumor

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE CANCER; CANCER SURGERY; CARTILAGE TUMOR; CHONDROSARCOMA; CONTRAST ENHANCEMENT; DESMOID TUMOR; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG RESPONSE; EWING SARCOMA; GIANT CELL TUMOR; HUMAN; LEIOMYOSARCOMA; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL TUMOR; MYXOMA; MYXOSARCOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFYING MYOSITIS; OSTEOSARCOMA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; SMALL CELL SARCOMA; SYNOVIAL SARCOMA; TUMOR DIFFERENTIATION; TUMOR NECROSIS; WHOLE BODY MRI;

BONE NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MUSCLE NEOPLASMS;

EID: 78649737040     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2010.10.007     Document Type: Review

References (55)

1. Van der Woude H.J., Verstraete K.L., Hogendoorn P.C., et al. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?. Radiology 1998, 208(3):821-828.
2. Kransdorf M.J., Murphey M.D. Imaging of soft tissue tumors. Allister LM, Barrett K, editors. Imaging of soft tissue tumors 2006, 38-79. Lippincott Williams & Wilkins, Philadelphia. 2nd edition.
3. Koh D.M., Takahara T., Imai Y., et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007, 6(4):211-224.
4. Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007, 188(6):1622-1635.
5. Nagata S., Nishimura H., Uchida M., et al. Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med 2008, 26(5):287-295.
6. Goudarzi B., Kishimoto R., Komatsu S., et al. Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy. Magn Reson Imaging 2010, 28(3):372-379.
7. Maeda M., Matsumine A., Kato H., et al. Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient. J Magn Reson Imaging 2007, 25(6):1199-1204.
8. Van Rijswijk C.S., Kunz P., Hogendoorn P.C., et al. Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging 2002, 15(3):302-307.
9. Oka K., Yakushiji T., Sato H., et al. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 2010, 39(2):141-146.
10. Baur A., Dietrich O., Reiser M. Diffusion-weighted imaging of bone marrow: current status. Eur Radiol 2003, 13(7):1699-1708.
11. Einarsdóttir H., Karlsson M., Wejde J., et al. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol 2004, 14(6):959-963.
12. Schnapauff D., Zeile M., Niederhagen M.B., et al. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging 2009, 29(6):1355-1359.
13. Uhl M., Saueressig U., van Buiren M., et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006, 41:618-623.
14. Stejskal E.O., Tanner J.E. Spin diffusion measurements: spin-echo in the presence of a time dependent field gradient. J Chem Phys 1965, 42:288-292.
15. Le Bihan D., Breton E., Lallemand D., et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988, 168:497-505.
16. Baur A., Reiser M.F. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 2000, 29(10):555-562.
17. Bley T.A., Wieben O., Uhl M. Diffusion-weighted MR imaging in musculoskeletal radiology: applications in trauma, tumors, and inflammation. Magn Reson Imaging Clin N Am 2009, 17(2):263-275.
18. Nagata S., Nishimura H., Uchida M., et al. Usefulness of diffusion-weighted MRI in differentiating benign from malignant musculoskeletal tumors. Nippon Igaku Hoshasen Gakkai Zasshi 2005, 65(1):30-36.
19. Sundaram M., Baran G., Merenda G., et al. Myxoid liposarcoma: magnetic resonance imaging appearances with clinical and histological correlation. Skeletal Radiol 1990, 19(5):359-362.
20. Guo A.C., Cummings T.J., Dash R.C., et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002, 224:177-183.
21. Nakayama T., Yoshimitsu K., Irie H., et al. Usefulness of the calculated apparent diffusion coefficient value in the differential diagnosis of retroperitoneal masses. J Magn Reson Imaging 2004, 20:735-742.
22. Sumi M., Ichikawa Y., Nakamura T. Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol 2007, 17:2631-2637.
23. King A.D., Ahuja A.T., Yeung D.K., et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007, 245:806-813.
24. Toh C.H., Castillo M., Wong A.M., et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008, 29:471-475.
25. Lee J.C., Thomas J.M., Phillips S., et al. Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol 2006, 186(1):247-254.
26. Lai P.H., Ho J.T., Chen W.L., et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 2002, 23(8):1369-1377.
27. Chang S.C., Lai P.H., Chen W.L., et al. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Clin Imaging 2002, 26(4):227-236.
28. Nakashima Y., Unni K.K., Shives T.C., et al. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 1986, 57(12):2444-2453.
29. Balsara Z.N., Stainken B.F., Martinez A.J. MR image of localized giant cell tumor of the tendon sheath involving the knee. J Comput Assist Tomogr 1989, 13(1):159-162.
30. Maheshwari A.V., Muro-Cacho C.A., Pitcher J.D. Pigmented villonodular bursitis/diffuse giant cell tumor of the pes anserine bursa: a report of two cases and review of literature. Knee 2007, 14(5):402-407.
31. Somerhausen N.S., Fletcher C.D. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol 2000, 24(4):479-492.
32. Goldenberg R.R., Campbell C.J., Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am 1970, 52(4):619-664.
33. Koh D.M., Thoeny H.C. Evaluation of malignant bone disease using DW-MRI. Diffusion-weighted MR imaging 2010, 207-226. Springer Berlin Heidelberg.
34. Hayashida Y., Yakushiji T., Awai K., et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results. Eur Radiol 2006, 16(12):2637-2643.
35. Erlemann R., Reiser M.F., Peters P.E., et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989, 171(3):767-773.
36. Holscher H.C., Bloem J.L., Vanel D., et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 1992, 182(3):839-844.
37. Padhani A.R., Khan A.A. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 2010, 5(1):39-52.
38. Padhani A.R., Liu G., Koh D.M., et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009, 11(2):102-125.
39. Kwee T.C., Takahara T., Klomp D.W., et al. Cancer imaging: novel concepts in clinical magnetic resonance imaging. J Intern Med 2010, 268:120-132.
40. Thoeny H.C., De Keyzer F., Chen F., et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 2005, 234(3):756-764.
41. Roth Y., Tichler T., Kostenich G., et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004, 232(3):685-692.
42. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000, 92(24):2029-2036.
43. Kamel I.R., Reyes D.K., Liapi E., et al. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2007, 18:49-56.
44. Schraml C., Schwenzer N.F., Martirosian P., et al. Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results. AJR Am J Roentgenol 2009, 193(4):W301-W307.
45. Theilmann R.J., Borders R., Trouard T.P., et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004, 6:831-837.
46. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson imaging 2006, 24:843-847.
47. Dudeck O., Zeile M., Pink D., et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 2008, 5:1109-1113.
48. Baur A., Huber A., Arbogast S., et al. Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur Radiol 2001, 11(5):828-833.
49. Kwee T.C., Takahara T., Ochiai R., et al. Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol 2009, 70(3):409-417.
50. Takahara T., Imai Y., Yamashita T., et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004, 22(4):275-282.
51. Kwee T.C., Takahara T., Ochiai R., et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008, 18(9):1937-1952.
52. Dietrich O., Biffar A., Baur-Melnyk A., et al. Technical aspects of MR diffusion imaging of the body. Eur J Radiol 2010, [Epub ahead of print].
53. Chen W., Jian W., Li H.T., et al. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?. Magn Reson Imaging 2010, 28(5):613-620.
54. Lin C., Luciani A., Itti E., et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010, 20:2027-2038.
55. Jacobs M.A., Pan L., Macura K.J. Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer. Semin Roentgenol 2009, 44(2):111-122.